ParcelBio

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://parcelbio.com/

Last Round

Seed

May 7, 2026

Total Funding Raised

$14M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

ParcelBio is a biotechnology company developing a new class of potent and durable mRNA medicines through its proprietary APEXm platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

synthetic biologygenetic medicinemRNA deliverydrug delivery platformgene therapytherapeutic cargobiotech platformprecision medicinetargeted deliveryRNA engineeringdrug discoverybiopharmain-vivo therapyprotein expressiondrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ParcelBio Comps

Public and private peers based on sector, stage, and business model.

ParcelBio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ParcelBio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	May 7, 2026
Seed Round	Mar 4, 2026
Seed	May 9, 2024
Pre Seed	Feb 1, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

David Weinberg

Co-Founder And CEO

Founding Team

ParcelBio Investors

Notable investors and investment history

ParcelBio investors
Investor	Rounds
Breyer Capital	Seed
Lexi Ventures	Seed
Pioneer Fund	Pre Seed
Ritual Capital	Seed, Seed Round
SBXi	Seed
Metaplanet Holdings	Seed
Surge Point Capital	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 7, 2026
$13M round led by Breyer Capital.
Mar 4, 2026
$13.17M raised in Seed Round.

View all signals

ParcelBio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ParcelBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ParcelBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range7

Year Founded2023

Last FundingMay 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.